Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-12-11

Clinical Trial Update: Does Dapagliflozin Promote Favorable Health Benefits That Are Independent Of Weight Loss? [Phase 2]

View source ↗

Summary

Phase 2 trial investigating whether dapagliflozin provides health benefits independent of weight loss; study terminated with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dapagliflozin (dapagliflozin)

Snippet

Sponsor: Christopher Bell | Conditions: Weight Loss | Phase 2 | Status: TERMINATED | Results posted: 2018-12-11